{"latest_checked": "2026-08-04T11:12:48.735903+00:00", "coverage_count": 5079, "recent_count": 13, "transaction_limit": 160, "filters": {"q": "", "ticker": "LGND", "sector": "", "industry": "", "side": "", "start": "2026-06-20", "end": "2026-08-04"}, "summary": {"total": 13, "acquisition_count": 4, "disposal_count": 9, "acquisition_value": 306509.3695, "acquisition_value_label": "$306.5K", "disposal_value": 1566376.9852, "disposal_value_label": "$1.6M", "net_value": -1259867.6157, "net_value_label": "$-1.3M", "flow_tone": "negative", "largest_value_label": "$348.8K", "top_sector": "Healthcare", "window_label": "20 Jun 2026 to 04 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 13, "value": "1872886.3547", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$1.9M"}], "days": [{"transaction_date": "2026-06-30", "acquisitions": 3, "disposals": 0, "total": 3, "bar_width": 30.0}, {"transaction_date": "2026-07-01", "acquisitions": 1, "disposals": 9, "total": 10, "bar_width": 100.0}], "side_mix": {"acquisitions": 4, "disposals": 9, "acquisition_share": 30.8, "disposal_share": 69.2}}, "company_flows": [{"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "acquisitions": 4, "disposals": 9, "acquired_value": 306509.3695, "acquired_value_label": "$306.5K", "disposed_value": 1566376.9852, "disposed_value_label": "$1.6M", "net_value": -1259867.6157, "net_value_label": "$-1.3M", "acquisition_share": 30.8, "disposal_share": 69.2, "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}], "company_overview": [{"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "filings": 13, "acquisitions": 4, "disposals": 9, "acquired_value": 306509.3695, "acquired_value_label": "$306.5K", "disposed_value": 1566376.9852, "disposed_value_label": "$1.6M", "net_value": -1259867.6157, "net_value_label": "$-1.3M", "acquisition_share": 30.8, "disposal_share": 69.2, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}], "transactions": [{"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1119.0, "share_price": 311.72, "transaction_value": 348814.68, "fetched_at": "2026-07-21T22:10:54.442097+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1081.0, "share_price": 312.2784, "transaction_value": 337572.9504, "fetched_at": "2026-07-21T22:10:54.443702+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 900.0, "share_price": 315.7775, "transaction_value": 284199.75, "fetched_at": "2026-07-21T22:10:54.431973+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5000.0, "share_price": 52.27, "transaction_value": 261350.0, "fetched_at": "2026-07-21T22:10:54.428992+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 700.0, "share_price": 313.4574, "transaction_value": 219420.18, "fetched_at": "2026-07-21T22:10:54.445301+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 600.0, "share_price": 317.1517, "transaction_value": 190291.02, "fetched_at": "2026-07-21T22:10:54.433743+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 396.0, "share_price": 308.9886, "transaction_value": 122359.4856, "fetched_at": "2026-07-21T22:10:54.440446+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 104.0, "share_price": 310.2023, "transaction_value": 32261.0392, "fetched_at": "2026-07-21T22:10:54.438670+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 100.0, "share_price": 314.5788, "transaction_value": 31457.88, "fetched_at": "2026-07-21T22:10:54.437086+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 5000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:10:54.435578+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "DAVIS, TODD C", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 132.0, "share_price": 160.7095, "transaction_value": 21213.654, "fetched_at": "2026-07-21T22:10:54.447089+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "REARDON, ANDREW", "executive_title": "CLO & Secretary", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 132.0, "share_price": 160.7095, "transaction_value": 21213.654, "fetched_at": "2026-07-21T22:10:54.448508+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}, {"symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "ESPINOZA, OCTAVIO", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 17.0, "share_price": 160.7095, "transaction_value": 2732.0615, "fetched_at": "2026-07-21T22:10:54.450544+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lgnd/", "research_links": {"chart": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/", "report": "/terminal/f1224815-cddd-4bfb-8dc3-fe2858461148/report/", "factor": "/factors/ticker/f1224815-cddd-4bfb-8dc3-fe2858461148/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}